Cargando…

Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma

Multiple myeloma (MM) progression is dependent on its interaction with the bone marrow microenvironment and the immune system and is mediated by key surface antigens. Some antigens promote adhesion to the bone marrow matrix and stromal cells, while others are involved in intercellular interactions t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lebel, Eyal, Nachmias, Boaz, Pick, Marjorie, Gross Even-Zohar, Noa, Gatt, Moshe E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000075/ https://www.ncbi.nlm.nih.gov/pubmed/35407416 http://dx.doi.org/10.3390/jcm11071809

Ejemplares similares

CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival
por: Gross Even-Zohar, Noa, et al.
Publicado: (2022)

Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of Interest
por: Nachmias, Boaz, et al.
Publicado: (2023)

Do older patients truly benefit from advances in myeloma care?
por: Gatt, Moshe E., et al.
Publicado: (2022)

The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia
por: Aumann, Shlomzion, et al.
Publicado: (2022)

The role of CD24 in multiple myeloma tumorigenicity and effects of the microenvironment on its expression
por: Gilad, Nechama, et al.
Publicado: (2019)

Amyloidogenic light chains impair plasma cell survival
por: Pick, Marjorie, et al.
Publicado: (2023)

Monitoring Minimal Residual Disease in RUNX1-Mutated Acute Myeloid Leukemia
por: Nachmias, Boaz, et al.
Publicado: (2022)

Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial
por: Asherie, Nathalie, et al.
Publicado: (2022)

Dose‐adjusted EPOCH‐R is not superior to sequential R‐CHOP/R‐ICE as a frontline treatment for newly diagnosed primary mediastinal B‐cell lymphoma: Results of a bi‐center retrospective study
por: Morgenstern, Yael, et al.
Publicado: (2021)

Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?
por: Vainstein, Vladimir, et al.
Publicado: (2023)

P914: VENETOCLAX IN RELAPSE/REFRACTORY AL AMYLOIDOSIS- A MULTICENTER INTERNATIONAL RETROSPECTIVE REAL-WORLD STUDY
por: Lebel, Eyal, et al.
Publicado: (2023)

Suppression of multiple myeloma by mitochondrial targeting
por: Aisen, Yana, et al.
Publicado: (2021)

Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study
por: Lebel, Eyal, et al.
Publicado: (2023)

Direct fluorescent-dye labeling of α-tubulin in mammalian cells for live cell and superresolution imaging
por: Schvartz, Tomer, et al.
Publicado: (2017)

Targeting nuclear import and export in hematological malignancies
por: Nachmias, Boaz, et al.
Publicado: (2020)

Mesenchymal stroma/stem cells: Haematologists’ friend or foe?
por: Nachmias, Boaz, et al.
Publicado: (2022)

COVID-19 Among Patients with Hematological Malignancies: Experience from a Tertiary Center Showing Lower Than Expected Mortality and Establishing the Safety of in-Hospital Patient Care during the Pandemic
por: Aumann, Shlomzion, et al.
Publicado: (2021)

P887: IN-HOUSE ANTI BCMA CAR-T THERAPY FOR THE TREATMENT OF RELAPSED REFRACTORY MULTIPLE MYELOMA: PHASE 1 RESULTS.
por: Asherie, N., et al.
Publicado: (2022)

Diagnostic and Management Difficulty of Bleeding Aorto-Duodenal Fistula Associated with Hodgkin’s Lymphoma
por: Nachmias, Boaz, et al.
Publicado: (2021)

Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma
por: Harush, Ortal, et al.
Publicado: (2022)

Tuberculosis Incidence in HIV/AIDS Patients in Israel, 1983–2010
por: Mor, Zohar, et al.
Publicado: (2013)

Erratum to: ‘HIV prevalence in the Israeli tuberculosis cohort, 1999–2011’
por: Mor, Zohar, et al.
Publicado: (2016)

HIV prevalence in the Israeli tuberculosis cohort, 1999–2011
por: Zohar, Mor, et al.
Publicado: (2014)

Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies
por: Lagreca, Ivana, et al.
Publicado: (2023)

CLASSIFICATION OF MYELOMA PROTEINS, BENCE JONES PROTEINS, AND MACROGLOBULINS INTO TWO GROUPS ON THE BASIS OF COMMON ANTIGENIC CHARACTERS
por: Mannik, Mart, et al.
Publicado: (1962)

An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma
por: Darawshi, Odai, et al.
Publicado: (2022)

Advances in the Understanding of Frontotemporal Dementia
por: Bandopadhyay, Rina, et al.
Publicado: (2023)

Utility of Galactomannan Screening for Early Detection of Invasive Aspergillosis in High-Risk Hemato-Oncology Patients
por: Sabbah, Rozan, et al.
Publicado: (2023)

Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study
por: Shragai, Tamir, et al.
Publicado: (2022)

COMMON INDIVIDUAL ANTIGENIC DETERMINANTS IN FIVE OF EIGHT BALB/c IGA MYELOMA PROTEINS THAT BIND PHOSPHORYL CHOLINE
por: Potter, Michael, et al.
Publicado: (1970)

The Contribution of a “Supportive Community” Program for Older Persons in Israel to Their Offspring Who Are Primary Caregivers
por: Even-Zohar, Ahuva
Publicado: (2015)

Recent advances in understanding multiple myeloma
por: Dhakal, Binod, et al.
Publicado: (2016)

Live Cell Imaging of Bioorthogonally Labelled Proteins Generated With a Single Pyrrolysine tRNA Gene
por: Aloush, Noa, et al.
Publicado: (2018)

A straightforward approach for bioorthogonal labeling of proteins and organelles in live mammalian cells, using a short peptide tag
por: Segal, Inbar, et al.
Publicado: (2020)

Common Adaptive Strategies Underlie Within-Host Evolution of Bacterial Pathogens
por: Gatt, Yair E, et al.
Publicado: (2020)

Study on the Relationship Between the Expression of B Cell Mature Antigen and the Classification, Stage, and Prognostic Factors of Multiple Myeloma
por: Ma, Tiantian, et al.
Publicado: (2021)

Prognostic significance of CD56 antigen in newly diagnosed multiple myeloma: A real-world retrospective study
por: Li, Liping, et al.
Publicado: (2022)

Recent Advances in the Understanding and Treatment of Multiple Myeloma
por: Cook, Richard, et al.
Publicado: (2008)

Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma
por: Kim, Dae Sik, et al.
Publicado: (2017)

Real-Time Stereo-Based Ocean Surface Mapping for Robotic Floating Platforms: Concept and Methodology
por: Greenberg, Or, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_54i5c7t0aapa7ht4s8rr1mu6o7